A matter of formulation: Efficacy and tolerability of nabiximols and cannabis decoction for the treatment of multiple sclerosis-related spasticity. (PubMed, Mult Scler Relat Disord) - Aug 14, 2026 - "Both nabiximols and cannabis decoction are effective for MS-related spasticity. Cannabis decoction may represent a viable option for patients who do not respond to or tolerate nabiximols. Differences in cannabinoid composition and pharmacokinetics may explain variations in outcomes. Prospective studies are needed to confirm these findings and optimize treatment strategies."
Journal • CNS Disorders • Movement Disorders • Multiple Sclerosis • Pain
|
|
Alberto Benussi; Alessandro Dinoto; Alessio Bratina; Anna Favero; Antonio Bosco; Arianna Sartori; Lucrezia Rossi; Marco Lotto; Paolo Manganotti; Sara Baldini; Stefano Colla
|